Literature DB >> 464590

Pharmacokinetic determinants of penicillin cure of gonococcal urethritis.

H W Jaffe, A L Schroeter, G H Reynolds, A A Zaidi, J E Martin, J D Thayer.   

Abstract

In a 1964 study of the pharmacokinetic determinants of penicillin cure of gonococcal urethritis, 45 male prisoner volunteers were experimentally infected with strains of Neisseria gonorrhoeae having known in vitro penicillin susceptibility. After developing urethritis, subjects received intramuscular penicillin G and had serum samples obtained serially to determine penicillin concentration. Using a multiple regression technique, we studied patient-associated parameters and parameters of the serum penicillin curves to determine the best predictors of treatment results. Cure was best predicted by the time the serum penicillin concentration remained above three to four times the penicillin minimum inhibitory concentration of the infecting strain (probability of correct classification, >0.80). Those cured had serum penicillin concentrations which remained in this range for means of 7 to 10 h. Our findings confirm principles of antimicrobial therapy derived from animal models and may have application in studying therapy of gonorrhea and other infectious diseases.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 464590      PMCID: PMC352715          DOI: 10.1128/AAC.15.4.587

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  A SELECTIVE MEDIUM FOR THE CULTIVATION OF N. GONORRHOEAE AND N. MENINGITIDIS.

Authors:  J D THAYER; J E MARTIN
Journal:  Public Health Rep       Date:  1964-01       Impact factor: 2.792

2.  Current status of the diagnosis and management of gonorrhea.

Authors:  W G SIMPSON; W J BROWN
Journal:  JAMA       Date:  1962-10-06       Impact factor: 56.272

3.  "Continuous" vs. "discontinuous" therapy with penicillin; the effect of the interval between injections on therapeutic efficacy.

Authors:  H EAGLE; R FLEISCHMAN; M LEVY
Journal:  N Engl J Med       Date:  1953-03-19       Impact factor: 91.245

4.  Effect of schedule of administration on the therapeutic efficacy of penicillin; importance of the aggregate time penicillin remains at effectively bactericidal levels.

Authors:  H EAGLE; R FLEISCHMAN; A D MUSSELMAN
Journal:  Am J Med       Date:  1950-09       Impact factor: 4.965

5.  The effective concentrations of penicillin in vitro and in vivo for streptococci, pneumococci, and Treponema pallidum.

Authors:  H EAGLE; R FLEISCHMAN; A D MUSSELMAN
Journal:  J Bacteriol       Date:  1950-05       Impact factor: 3.490

6.  Problems in diagnosis, treatment and control of gonorrheal infections. IV. The correlation between the dose of penicillin, concentration in blood, IC-50-values of gonococci and results of treatment.

Authors:  G Krook; I Juhlin
Journal:  Acta Derm Venereol       Date:  1965       Impact factor: 4.437

7.  NEISSERIA GONORRHOEAE IDENTIFICATION IN DIRECT SMEARS BY A FLUORESCENT ANTIBODY-COUNTERSTAIN METHOD.

Authors:  L A WHITE; D S KELLOGG
Journal:  Appl Microbiol       Date:  1965-03

8.  Surveillance studies on Neisseria gonorrhoea sensitivity to penicillin and nine other antibiotics.

Authors:  J D THAYER; F W FIELD; M I PERRY; J E MARTIN; W GARSON
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

9.  NEISSERIA GONORRHOEAE. I. VIRULENCE GENETICALLY LINKED TO CLONAL VARIATION.

Authors:  D S KELLOGG; W L PEACOCK; W E DEACON; L BROWN; D I PIRKLE
Journal:  J Bacteriol       Date:  1963-06       Impact factor: 3.490

View more
  19 in total

Review 1.  The use of cephalosporins for gonorrhea: an update on the rising problem of resistance.

Authors:  Juliet E Stoltey; Pennan M Barry
Journal:  Expert Opin Pharmacother       Date:  2012-05-30       Impact factor: 3.889

Review 2.  Preparing for an era of untreatable gonorrhea.

Authors:  Lindley A Barbee
Journal:  Curr Opin Infect Dis       Date:  2014-06       Impact factor: 4.915

3.  [Multi-step increase in resistance of Neisseria gonorrhoeae isolates after repeated in-vitro subinhibitory concentrations of second-generation quinolones].

Authors:  H C Korting; A Lukacs
Journal:  Infection       Date:  1989       Impact factor: 3.553

4.  Measurement of bactericidal activity in body fluids as a clinical research procedure.

Authors:  P Dejace; J Klastersky
Journal:  Eur J Clin Microbiol       Date:  1986-02       Impact factor: 3.267

5.  Penicillin sensitivities of gonoccocci, in 1977-80 from a peripheral health district, and their clinical correlation.

Authors:  M Rahman
Journal:  Postgrad Med J       Date:  1982-02       Impact factor: 2.401

6.  Determination of antibiotic effect in an in vitro pharmacodynamic model: comparison with an established animal model of infection.

Authors:  Charles R Bonapace; Lawrence V Friedrich; John A Bosso; Roger L White
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

7.  Therapeutic trial and pharmacokinetics of sulbactam for uncomplicated gonorrhea in men.

Authors:  V A Caine; G Foulds; H H Handsfield
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

Review 8.  Beta-lactams in sexually transmitted diseases: rationale for selection and dosing regimens.

Authors:  D Kunimoto; R Brunham; A Ronald
Journal:  Eur J Clin Microbiol       Date:  1984-12       Impact factor: 3.267

9.  Proposed criteria for interpretation of susceptibilities of strains of Neisseria gonorrhoeae to ciprofloxacin, ofloxacin, enoxacin, lomefloxacin, and norfloxacin.

Authors:  J S Knapp; J A Hale; S W Neal; K Wintersheid; R J Rice; W L Whittington
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

10.  Antimicrobial breakpoint estimation accounting for variability in pharmacokinetics.

Authors:  Goue Denis Gohore Bi; Jun Li; Fahima Nekka
Journal:  Theor Biol Med Model       Date:  2009-06-26       Impact factor: 2.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.